BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10986803)

  • 1. Naltrexone treatment of self-injurious behavior.
    Godart NT; Agman G; Perdereau F; Jeammet P
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical anorexia in a male patient accompanied by strong obsessive-compulsive symptoms successfully treated with naltrexone.
    Gade K; Häussinger C; Bandelow B
    Pharmacopsychiatry; 2009 Jul; 42(4):164-5. PubMed ID: 19585396
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of obsessive-compulsive cutting behavior with naltrexone.
    Bystritsky A; Strausser BP
    J Clin Psychiatry; 1996 Sep; 57(9):423-4. PubMed ID: 9746454
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychotropic medication use in people with developmental disabilities.
    Curtis JL
    Md Med J; 1997 Oct; 46(9):481-5. PubMed ID: 9327650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
    Bolm T; Piegler T
    Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of naltrexone on self-injurious behavior.
    Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM
    Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.
    Curtis AR; Richards RW
    Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone treatment for a 3-year-old boy with self-injurious behavior.
    White T; Schultz SK
    Am J Psychiatry; 2000 Oct; 157(10):1574-82. PubMed ID: 11007709
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors.
    Sasso DA; Kalanithi PS; Trueblood KV; Pittenger C; Kelmendi B; Wayslink S; Malison RT; Krystal JH; Coric V
    J Clin Psychopharmacol; 2006 Dec; 26(6):685-7. PubMed ID: 17110840
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
    Elchaar GM; Maisch NM; Augusto LM; Wehring HJ
    Ann Pharmacother; 2006 Jun; 40(6):1086-95. PubMed ID: 16735648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of opiate antagonists for recurrent self-injurious behavior.
    Buzan RD; Thomas M; Dubovsky SL; Treadway J
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):437-44. PubMed ID: 8555746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of vision secondary to obsessive-compulsive disorder: a case report.
    Torres AR; Domingues Mde S; Shiguematsu AI; Smaira SI
    Gen Hosp Psychiatry; 2009; 31(3):292-4. PubMed ID: 19410110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic agents in dermatology.
    Koo JY
    Dermatol Clin; 1993 Jan; 11(1):215-24. PubMed ID: 8435914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult head-banging and stereotypic movement disorders.
    Mendez MF; Mirea A
    Mov Disord; 1998 Sep; 13(5):825-8. PubMed ID: 9756153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone as a treatment of self-injurious behavior: a case report.
    Griengl H; Dantendorfer K
    Eur Psychiatry; 2001 Apr; 16(3):193-4. PubMed ID: 11353600
    [No Abstract]   [Full Text] [Related]  

  • 18. Naltrexone and fluoxetine in Prader-Willi syndrome.
    Benjamin E; Buot-Smith T
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone in patients with bipolar disorder and alcohol dependence.
    Brown ES; Beard L; Dobbs L; Rush AJ
    Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone in autistic children: behavioral symptoms and attentional learning.
    Campbell M; Anderson LT; Small AM; Adams P; Gonzalez NM; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1283-91. PubMed ID: 8282676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.